Skip to main content
Top

Angiogenesis

Issue 2/2004

Content (10 Articles)

Hanging-drop multicellular spheroids as a model of tumour angiogenesis

Nicholas Timmins, Stefanie Dietmair, Lars Nielsen

Inhibition of FGF receptor activity in glioma implanted into the mouse brain using the tetracyclin-regulated expression system

Sylvain Miraux, Sylvie Lemière, Raphael Pineau, Mauro Pluderi, Paul Canioni, Jean-michel Franconi, Eric Thiaudière, Lorenzo Bello, Andreas Bikfalvi, Patrick Auguste

Withaferin A is a potent inhibitor of angiogenesis

Royce Mohan, Hans Hammers, Paola Bargagna-mohan, Xiaoguo Zhan, Christopher Herbstritt, Antonio Ruiz, Li Zhang, Art Hanson, Barry Conner, John Rougas, Victor Pribluda

Protamine enhances uptake of cationic liposomes in angiogenic microvessels of solid tumours

M.E. Eichhorn, S. Strieth, S. Krasnici, B. Sauer, M. Teifel, U. Michaelis, K. Naujoks, M. Dellian

Bioinformatic analysis of primary endothelial cell gene array data illustrated by the analysis of transcriptome changes in endothelial cells exposed to VEGF-A and PlGF

Jonathan Schoenfeld, Khashayar Lessan, Nicola Johnson, D. Charnock-jones, Amanda Evans, Ekaterini Vourvouhaki, Laurie Scott, Richard Stephens, Tom Freeman, Samir Saidi, Brian Tom, Gareth Weston, Peter Rogers, Stephen Smith, Cristin Print

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.